Fundraising Fox

Biotech Series A Investors & VC Firms

1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.

GS Futures
SeoulSeed–Series A
15 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.3M
11 people
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
NOON Ventures
CopenhagenSeed–Series A$500K – $10M
17 people
AIR Capital
Buenos AiresPre-Seed–Series A
2 people
Alix Ventures
San FranciscoPre-Seed–Series A$100K – $500K
19 people
RDiscovery
TokyoPre-Seed–Series A
19 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
7 people
V-Bio Ventures
GhentSeed–Growth$270K – $2.2M
13 people
NovaCapital
Seed–Late Stage
9 people
Oxford Technology Management
OxfordPre-Seed–Series A$200K – $400K
6 people
Sandwater
OsloSeed–Series B$2.2M – $11M
12 people
Shackleton Ventures Ltd.
LondonSeed–Series A$952.5K – $25.4M
6 people
Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
19 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
WELL Ventures
VancouverSeed–Growth
16 people
SCI Ventures
LondonSeed–Series B
18 people
Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
SyndicateRoom
CambridgePre-Seed–Series A
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Capital2B
New DelhiPre-Seed–Series A$200K – $3M
11 people
Merak Ventures
New DelhiPre-Seed–Series A$500K – $1.5M
10 people
Big Red Ventures
IthacaPre-Seed–Series A$25K
18 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.